IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma
Go back to IN8bio Presents New Translational Data Demonstrating DeltEx DRI Reshapes the Immune Landscape in Glioblastoma| (NASDAQ: INAB) | Delayed: 1.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.34 | 52 Week High | $ | |||
| Open | $1.34 | 52 Week Low | $ | |||
| Day High | $1.34 | P/E | N/A | |||
| Day Low | $1.34 | EPS | $ | |||
| Volume | 8 | |||||

